Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001218815-26-000002

Options or other derivatives

  • Director acquired 26,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CONRAD HERBERT J Director 2026-06-25 Grant or award · Non-Qualified Stock Option (right to buy) +26,000 26,000 D
Loading xslF345X06/form4-06292026_080622.xml…